Insurance companies approved 85% of requests for drugs for which reimbursement is exception-based
…drugs in the long-term in the category of those based on exception are antineoplastics and immunomodulators (approximately 70% of the total cost), and these include drugs designed for the treatment of patients with oncological diseases, and haematological, nephric and neuromuscular disorders.
Sign up now to open the entire news item.You are allowed to open only one news item from PMR websites.
(to send requested information)
(required for new e-mails only)